Ideaya Biosciences Inc (IDYA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 112,825 | 298,927 | 114,645 | 129,996 | 84,378 |
| Marketable Securities | 526,563 | 487,967 | 555,093 | 562,512 | 591,941 |
| Other current assets | 5,973 | 0 | 0 | 0 | 0 |
| TOTAL | $666,727 | $802,655 | $685,602 | $707,872 | $689,713 |
| Non-Current Assets | |||||
| PPE Net | 8,217 | 8,172 | 8,819 | 8,871 | 8,966 |
| Investments And Advances | 410,297 | 349,960 | 322,131 | 358,665 | 405,832 |
| Other Non-Current Assets | 24,083 | 24,349 | 24,718 | 25,233 | 19,580 |
| TOTAL | $442,597 | $382,481 | $355,668 | $392,769 | $434,378 |
| Total Assets | $1,109,324 | $1,185,136 | $1,041,270 | $1,100,641 | $1,124,091 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 17,584 | 18,433 | 17,270 | 17,631 | 15,421 |
| Accrued Expenses | 40,892 | 45,258 | 37,750 | 32,907 | 30,352 |
| Other current liabilities | N/A | 490 | N/A | N/A | N/A |
| TOTAL | $58,815 | $64,509 | $55,338 | $50,846 | $46,071 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 27,575 | 28,593 | 26,279 | 25,660 | 18,873 |
| TOTAL | $27,575 | $28,593 | $26,279 | $25,660 | $18,873 |
| Total Liabilities | $86,390 | $93,102 | $81,617 | $76,506 | $64,944 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 87,814 | 87,666 | 87,644 | 87,582 | 87,537 |
| Common Shares | 9 | 9 | 9 | 9 | 9 |
| Retained earnings | -736,539 | -653,266 | -772,510 | -695,019 | -622,841 |
| Other shareholders' equity | 2,267 | 2,052 | 1,521 | 1,585 | 812 |
| TOTAL | $1,022,934 | $1,092,034 | $959,653 | $1,024,135 | $1,059,147 |
| Total Liabilities And Equity | $1,109,324 | $1,185,136 | $1,041,270 | $1,100,641 | $1,124,091 |